1 Cited authority

  1. Teva Pharmaceuticals USA, Inc. v. Pfizer, Inc.

    395 F.3d 1324 (Fed. Cir. 2005)   Cited 68 times   2 Legal Analyses
    Holding that the listing of patent FDA's Orange Book, without more, should not be construed as blanket threat to potential infringers